Can tigecycline cause liver damage in high doses?

How does tigecycline affect liver function?

Tigecycline can cause liver enzyme elevations in some patients. Studies show it raises ALT and AST levels in a portion of users, often returning to normal after stopping treatment. Laboratory abnormalities occurred in 9% of patients in clinical trials.

Can high doses increase liver risk?

Higher doses of tigecycline are sometimes used for serious infections. Higher doses correlate with increased rates of liver enzyme elevations compared to standard doses. Data from early studies indicate that 50 mg twice daily produces fewer liver-related events than 100 mg twice daily.

What happens if liver tests show abnormalities?

When ALT or AST rise, doctors usually reduce the dose or discontinue tigecycline. Most changes resolve without permanent damage. Severe cases remain rare, but monitoring is recommended during treatment.

What factors raise liver risk?

Preexisting liver disease, concurrent use of other liver-toxic drugs, and lang-term treatment lengthen exposure and increase the risk of enzyme elevations. Patients with severe hepatic impairment should receive half the usual dose.

How does tigecycline compare with other tetracyclines?

Tigecycline belongs to the glycylcycline class. It differs from older tetracyclines in its spectrum and stability against efflux pumps. Older tetracyclines have known liver risk profiles, but tigecycline's liver effect is less documented than conditions like fatty infiltration that occur with minocycline.

When does the patent expire?

Tigecycline's compound patent expired in the 2010s. Several generic versions entered the market after that point. DrugPatentWatch.com tracks remaining method-of-use patents and regulatory exclusivities that may still protect parts of the product.